IBDEI1GN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25912,1,2,0)
 ;;=2^304.32
 ;;^UTILITY(U,$J,358.3,25912,1,5,0)
 ;;=5^Cannabis Depend, Episodic
 ;;^UTILITY(U,$J,358.3,25912,2)
 ;;=^268202
 ;;^UTILITY(U,$J,358.3,25913,0)
 ;;=304.41^^150^1647^20
 ;;^UTILITY(U,$J,358.3,25913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25913,1,2,0)
 ;;=2^304.41
 ;;^UTILITY(U,$J,358.3,25913,1,5,0)
 ;;=5^Amphetamine Depend, Continuous
 ;;^UTILITY(U,$J,358.3,25913,2)
 ;;=^268205
 ;;^UTILITY(U,$J,358.3,25914,0)
 ;;=304.42^^150^1647^21
 ;;^UTILITY(U,$J,358.3,25914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25914,1,2,0)
 ;;=2^304.42
 ;;^UTILITY(U,$J,358.3,25914,1,5,0)
 ;;=5^Amphetamine Depend, Episodic
 ;;^UTILITY(U,$J,358.3,25914,2)
 ;;=^268206
 ;;^UTILITY(U,$J,358.3,25915,0)
 ;;=304.51^^150^1647^60
 ;;^UTILITY(U,$J,358.3,25915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25915,1,2,0)
 ;;=2^304.51
 ;;^UTILITY(U,$J,358.3,25915,1,5,0)
 ;;=5^Hallucinogen Depend, Continuous
 ;;^UTILITY(U,$J,358.3,25915,2)
 ;;=^268208
 ;;^UTILITY(U,$J,358.3,25916,0)
 ;;=304.52^^150^1647^61
 ;;^UTILITY(U,$J,358.3,25916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25916,1,2,0)
 ;;=2^304.52
 ;;^UTILITY(U,$J,358.3,25916,1,5,0)
 ;;=5^Hallucinogen Depend, Episodic
 ;;^UTILITY(U,$J,358.3,25916,2)
 ;;=^268209
 ;;^UTILITY(U,$J,358.3,25917,0)
 ;;=304.61^^150^1647^52
 ;;^UTILITY(U,$J,358.3,25917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25917,1,2,0)
 ;;=2^304.61
 ;;^UTILITY(U,$J,358.3,25917,1,5,0)
 ;;=5^Drug Depend-Other, Continuous
 ;;^UTILITY(U,$J,358.3,25917,2)
 ;;=^268211
 ;;^UTILITY(U,$J,358.3,25918,0)
 ;;=304.62^^150^1647^53
 ;;^UTILITY(U,$J,358.3,25918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25918,1,2,0)
 ;;=2^304.62
 ;;^UTILITY(U,$J,358.3,25918,1,5,0)
 ;;=5^Drug Depend-Other, Episodic
 ;;^UTILITY(U,$J,358.3,25918,2)
 ;;=^268212
 ;;^UTILITY(U,$J,358.3,25919,0)
 ;;=304.71^^150^1647^66
 ;;^UTILITY(U,$J,358.3,25919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25919,1,2,0)
 ;;=2^304.71
 ;;^UTILITY(U,$J,358.3,25919,1,5,0)
 ;;=5^Opioid + Other Depend, Continuous
 ;;^UTILITY(U,$J,358.3,25919,2)
 ;;=^268215
 ;;^UTILITY(U,$J,358.3,25920,0)
 ;;=304.72^^150^1647^67
 ;;^UTILITY(U,$J,358.3,25920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25920,1,2,0)
 ;;=2^304.72
 ;;^UTILITY(U,$J,358.3,25920,1,5,0)
 ;;=5^Opioid + Other Depend, Episodic
 ;;^UTILITY(U,$J,358.3,25920,2)
 ;;=^268216
 ;;^UTILITY(U,$J,358.3,25921,0)
 ;;=304.81^^150^1647^48
 ;;^UTILITY(U,$J,358.3,25921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25921,1,2,0)
 ;;=2^304.81
 ;;^UTILITY(U,$J,358.3,25921,1,5,0)
 ;;=5^Comb Drug Depend, Continuous
 ;;^UTILITY(U,$J,358.3,25921,2)
 ;;=^268219
 ;;^UTILITY(U,$J,358.3,25922,0)
 ;;=304.82^^150^1647^49
 ;;^UTILITY(U,$J,358.3,25922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25922,1,2,0)
 ;;=2^304.82
 ;;^UTILITY(U,$J,358.3,25922,1,5,0)
 ;;=5^Comb Drug Depend, Episodic
 ;;^UTILITY(U,$J,358.3,25922,2)
 ;;=^268220
 ;;^UTILITY(U,$J,358.3,25923,0)
 ;;=305.01^^150^1647^1
 ;;^UTILITY(U,$J,358.3,25923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25923,1,2,0)
 ;;=2^305.01
 ;;^UTILITY(U,$J,358.3,25923,1,5,0)
 ;;=5^Alc Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,25923,2)
 ;;=^268228
 ;;^UTILITY(U,$J,358.3,25924,0)
 ;;=305.02^^150^1647^2
 ;;^UTILITY(U,$J,358.3,25924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25924,1,2,0)
 ;;=2^305.02
 ;;^UTILITY(U,$J,358.3,25924,1,5,0)
 ;;=5^Alc Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,25924,2)
 ;;=^268229
 ;;^UTILITY(U,$J,358.3,25925,0)
 ;;=305.21^^150^1647^32
 ;;^UTILITY(U,$J,358.3,25925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25925,1,2,0)
 ;;=2^305.21
 ;;
 ;;$END ROU IBDEI1GN
